TNFRSF4 and neoplasm: Tumor infiltrating Tregs show an activated phenotype characterized by the expression of PD-1 and OX40 (Piconese et al., 2014; Kamada et al., 2019; Polesso et al., 2019), that holds potential for modulating their abundance in the tumor microenvironment with therapeutic implications.